LumiraDx Announces Agreement to Sell its Cutting Edge Point of Care Technology Platform to Roche

Contributed by: GlobeNewswire

Tags

LumiraDx

More Like This

GlobeNewswire associated0

LumiraDx Partners with AstraZeneca & Everton in the Community to Set Up England’s First Heart & Lung Screening Hub

LUMA Vision Co-Founders, CEO Fionn Lahart (right) and Chief Technology Officer Christoph Hennersperger (left). (Photo: Business Wire)

LUMA Vision Announces $22 Million in New Financing to Secure FDA Approval and Advance Development of 4D Cardiac Imaging and Navigation Platform

Caldera Medical Acquires UVision360 and the LUMINELLE Product Family, Expanding Minimally Invasive Hysteroscopy Portfolio

PR Newswire associated0

Trudell Medical Limited expanding into respiratory diagnostics with agreement to acquire Vyaire Medical RDx

LuminUltra Acquires Legionella Testing Business from Genomadix and Inks Strategic License to Commercialize Additional Tests for Ultra-portable Molecular Diagnostic Platform

PR Newswire associated0

Telix Announces Reorganisation to Deliver on Strategic Priorities

PR Newswire associated0

Telix to Acquire RLS to Expand North American Manufacturing and Distribution Platform

AliveDx Announces Turnkey Solution for Precise, Automated Autoimmune Diagnostics